Logo image of ALDR

Alder Biopharmaceuticals Inc (ALDR) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:ALDR -

18.88
-0.04 (-0.21%)
Last: 10/21/2019, 8:00:00 PM
18.88
0 (0%)
After Hours: 10/21/2019, 8:00:00 PM

ALDR Key Statistics, Chart & Performance

Key Statistics
Market Cap1.58B
Revenue(TTM)N/A
Net Income(TTM)-317.35M
Shares83.84M
Float35.34M
52 Week High19.12
52 Week Low8.39
Yearly Dividend0
Dividend Yield0%
EPS(TTM)-4.45
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


ALDR short term performance overview.The bars show the price performance of ALDR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60 80

ALDR long term performance overview.The bars show the price performance of ALDR in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40

The current stock price of ALDR is 18.88 null. In the past month the price increased by 1.34%. In the past year, price increased by 43.36%.

Alder Biopharmaceuticals Inc / ALDR Daily stock chart

ALDR Latest News, Press Relases and Analysis

About ALDR

Company Profile

Alder Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and seeks to commercialize therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, for the prevention of migraine; and Clazakizumab, in the treatment of rheumatoid arthritis and psoriatic arthritis. Alder Biopharmaceuticals Inc. is headquartered in Bothell, Washington.

Company Info

Alder Biopharmaceuticals Inc

11804 NORTH CREEK PARKWAY SOUTH

BOTHELL WA 98011

CEO: Robert W. Azelby

Phone: 425-205-2900

Alder Biopharmaceuticals Inc / ALDR FAQ

Can you describe the business of Alder Biopharmaceuticals Inc?

Alder Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and seeks to commercialize therapeutic antibodies. It is developing monoclonal antibodies comprising ALD403, for the prevention of migraine; and Clazakizumab, in the treatment of rheumatoid arthritis and psoriatic arthritis. Alder Biopharmaceuticals Inc. is headquartered in Bothell, Washington.


Can you provide the latest stock price for Alder Biopharmaceuticals Inc?

The current stock price of ALDR is 18.88 null. The price decreased by -0.21% in the last trading session.


What is the dividend status of Alder Biopharmaceuticals Inc?

ALDR does not pay a dividend.


What is the ChartMill rating of Alder Biopharmaceuticals Inc stock?

ALDR has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Is Alder Biopharmaceuticals Inc (ALDR) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALDR.


What is the market capitalization of ALDR stock?

Alder Biopharmaceuticals Inc (ALDR) has a market capitalization of 1.58B null. This makes ALDR a Small Cap stock.


ALDR Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to ALDR. When comparing the yearly performance of all stocks, ALDR is one of the better performing stocks in the market, outperforming 98.26% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ALDR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ALDR. Both the profitability and financial health of ALDR have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALDR Financial Highlights

Over the last trailing twelve months ALDR reported a non-GAAP Earnings per Share(EPS) of -4.449999999999999. The EPS increased by 0.89% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -68.61%
ROE N/A
Debt/Equity 0.89
Chartmill High Growth Momentum
EPS Q2Q%30.77%
Sales Q2Q%N/A
EPS 1Y (TTM)0.89%
Revenue 1Y (TTM)-100%

ALDR Forecast & Estimates


Analysts
Analysts78.2
Price TargetN/A
EPS Next Y19.51%
Revenue Next YearN/A

ALDR Ownership

Ownership
Inst Owners87.48%
Ins Owners5.38%
Short Float %N/A
Short RatioN/A